Information  X 
Enter a valid email address
  Print          More announcements

Thursday 29 July, 2021

Peel Hunt LLP

Form 8.5 (EPT/RI) - UDG Healthcare Plc

RNS Number : 9118G
Peel Hunt LLP
29 July 2021
 

Ap24

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.  KEY INFORMATION

 

Name of exempt principal trader

Peel Hunt LLP

Company dealt in

UDG Healthcare Plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

EUR 05.5 Ordinary Shares

Date of dealing

28 July 2021

 

2.  DEALINGS (Note 2)

 

(a)  Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

1,314

 

1078.12 GBP

1078.01 GBP

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

1,316

1078.99 GBP

1078.00 GBP

 

(b)  Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)



 Nil



Ap25

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)








 

 

(ii)  Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)


 Nil


 

 

3.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

  None

 

 

 

 

Date of disclosure

 29 July 2021

Contact name

 Kathleen Lloyd

Telephone number

 0207 418 8911

Name of offeree/offeror with which connected

 UDG Healthcare Plc

Nature of connection (Note 6)

 Broker to Offeree

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUKOKRAOUBURR

a d v e r t i s e m e n t